Pharmalicensing.com: PR Newswire http://pharmalicensing.com/rss/ Latest market and business intelligence from the leading publishers worldwide. en-us Pharmalicensing.com: PR Newswire http://pharmalicensing.com/rss/ http://pharmalicensing.com/images/pharmalicensing_logo.gif 144 U.S. and European Experts Applaud Creation of New Transatlantic Task Force on Global Antibiotic Resistance Threat WASHINGTON, November 6 /PRNewswire/ -- Experts on both sides of the Atlantic applaud President Barack Obama and Swedish Prime Minister Fredrik Reinfeldt, representing the European Union (EU)... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3944 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3944 Fri, 06 Nov 2009 17:06:00 +0000 Mouth Cancer - A Deadly Disease - On the Increase LONDON, November 6 /PRNewswire/ -- Mouth cancer (also called oral cancer) is a malignant growth which can occur in any part of the mouth including the lips and tongue. In the UK, the numbers of new... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3943 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3943 Fri, 06 Nov 2009 13:24:00 +0000 Ortho Clinical Diagnostics Launches First-of-its-kind Remote Monitoring Center in Europe PARIS, November 6 /PRNewswire/ -- Ortho Clinical Diagnostics (OCD) today announced the launch of a first-of-its-kind 24-7 central command center in Strasbourg, France, that continuously tracks the... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3942 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3942 Fri, 06 Nov 2009 09:56:00 +0000 Internet Sales of Dermocosmetics: the Paris Court of Appeal Refers the Case to the Court of Justice of the European Communities CASTRES, France, November 6 /PRNewswire/ -- The case opposing the French Competition Authority and Pierre Fabre Dermocosmetics (PFDC) came before the Paris Court of Appeal on Thursday, 29 October... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3941 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3941 Fri, 06 Nov 2009 09:24:00 +0000 Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) PARIS, November 6 /PRNewswire/ -- Novexel, a speciality pharmaceutical company focused on the discovery and development of novel antibiotics designed to overcome the significant global problem of... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3940 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3940 Fri, 06 Nov 2009 08:00:00 +0000 Allied World Reports Record Operating Results in Third Quarter 2009; 27.4% Increase in Total Book Value Year to Date; 11% Dividend Increase Announced PEMBROKE, Bermuda, November 5 /PRNewswire/ -- Allied World Assurance Company Holdings, Ltd (NYSE: AWH) today reported net income of $200.6 million, or $3.83 per diluted share, for the third quarter... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3939 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3939 Thu, 05 Nov 2009 23:19:00 +0000 Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts AURORA, Ontario, November 5 /PRNewswire/ -- Helix BioPharma Corp. (TSX, FSE: "HBP" / OTCQX: HXBPF) announced today that its Phase II trial of Topical Interferon Alpha-2b for the treatment... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3938 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3938 Thu, 05 Nov 2009 23:08:00 +0000 Novel Laser Coding Technology for Pharmaceutical Glass Containers ST GALLEN, Switzerland, November 5 /PRNewswire/ -- A completely new innovative laser-coding system enables glass containers for parenteral use to be clearly coded at the glass syringe manufacturer... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3937 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3937 Thu, 05 Nov 2009 16:43:00 +0000 Sirius Genomics received NRC-IRAP Funding for Continued Development of a Sepsis Companion Diagnostic VANCOUVER, November 5 /PRNewswire/ -- Sirius Genomics, a developer of pharmacogenomic diagnostics, announced today that it has signed its first Contribution Agreement with the National Research... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3936 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3936 Thu, 05 Nov 2009 12:58:00 +0000 Breast Enlargement Day Case Operations Increase by 235 per Cent LONDON, November 5 /PRNewswire/ -- Breast enlargement operations performed as day case operations have soared in the past 15 years, seeing a whopping 235 per cent increase, UK cosmetic surgeons... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3935 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3935 Thu, 05 Nov 2009 07:55:00 +0000